AstraZeneca - Top 5 layoffs of 2008

Company: AstraZeneca
Layoffs: 1,400

Summary: As part of an"ongoing program to improve efficiency across the business," AstraZeneca said it would shutter three European plans in Porriño in Spain, Destelbergen in Belgium and Umeå in Sweden. The closings, which will be completed by 2013, will leave 1,400 employees out of work. There will be roles affected at AstraZeneca's Macclesfield, UK and Södertälje, Sweden facilities as well. These cuts are in addition to the 7,600 announced in 2007, which earned the company the number two spot on our list last year. The jobs will head to China, where AstraZeneca is further investing in its Wuxi PharmaTech plant. The company said the changes will make its overall manufacturing and supply chain more efficient.

AstraZeneca - Top 5 layoffs of 2008
Read more on

Suggested Articles

Bluebird Bio has overcome a manufacturing hiccup that looked like it would delay its gene therapy launch in Europe until next year.

Lilly's top U.S. executive is on his way out. Enrique Conterno, who also heads up Lilly's global diabetes business, will step down at year's end.

GlaxoSmithKline, Pfizer, Sanofi and Boehringer Ingelheim are facing lawsuit claims that they failed to test for possible carcinogens in Zantac.